KalVista Pharmaceuticals, Inc. (KALV)
16.18
+0.50
(+3.19%)
USD |
NASDAQ |
Dec 31, 16:00
16.18
0.00 (0.00%)
After-Hours: 20:00
KalVista Pharmaceuticals Market Cap: 817.84M for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| BioCryst Pharmaceuticals, Inc. | 1.644B |
| Silvergate Capital Corp. | 293.37M |
| Perspective Therapeutics, Inc. | 204.06M |
| Electromed, Inc. | 241.96M |
| Xtant Medical Holdings, Inc. | 109.20M |
Market Cap Related Metrics
| PS Ratio | 56.13 |
| PEG Ratio | -0.3942 |
| Price to Book Value | 48.11 |
| Price | 16.18 |
| Earnings Yield | -24.80% |
| PEGY Ratio | -0.3942 |